The BIA’s eight Advisory Committees are crucial mechanisms for highlighting the most relevant issues facing bioscience companies.

Committee meetings provide forums for BIA members to get involved, network with peers and discuss best practices. Their work informs and guides BIA policy and priorities, ensuring that member needs are met.

Committee members include influential experts from across the sector. Being part of an Advisory Committee helps shape the future of UK biotech and ensure the success of the sector.

Cell and Gene Therapy Advisory Committee (CGTAC)

The BIA CGTAC was established to highlight the value of cell and gene therapies to patients and the wider UK economy.

Engineering Biology Advisory Committee (EBAC)

The BIA EBAC is composed of industry experts in engineering/synthetic biology and provides a forum to discuss key issues.

Finance and Tax Advisory Committee (FTAC)

The FTAC guides the BIA’s policies and initiatives to create a supportive financial environment for the innovative life sciences and biotech companies...

Manufacturing Advisory Committee (MAC)

The BIA MAC supports the UK bio-medicine manufacturing community by addressing issues relevant to the biologics, vaccine, cell & gene therapy sector.

Regulatory Affairs Advisory Committee (RAAC)

The RAAC committee supports the BIA’s regulatory affairs activity and provides the opportunity for BIA members to contribute to its agenda.

Science and Innovation Advisory Committee (SIAC)

The BIA SIAC was set up to identify and build on evolving science trends in the biotech industry that can give the UK a competitive advantage.

Intellectual Property Advisory Committee (IPAC)

The IPAC helps the BIA shape the environment for IP ownership and protection.

Genomics Advisory Committee (GAC)

The BIA GAC ensures that the UK starts, scales and builds world-leading genomic businesses.